| Issue |
Section |
Title |
File |
| Vol 79, No 7 (2004) |
Editorial |
Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias |
|
| Vol 79, No 7 (2004) |
Editorial |
Molecular-cytogenetic monitoring of different regimens of treatment |
|
| Vol 79, No 7 (2004) |
Editorial |
Prediction of interferon therapy efficacy in chronic myeloid leukemia according to histomorphological evidence |
|
| Vol 79, No 7 (2004) |
Editorial |
Glivek in therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome |
|
| Vol 81, No 7 (2009) |
Editorial |
Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosinkinases |
|
| Vol 81, No 7 (2009) |
Editorial |
Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase |
|
| Vol 82, No 12 (2010) |
Editorial |
Study of bone marrow microvessel density is one of the diagnostic approaches in patients with Ph-negative chronic myeloproliferative diseases |
|
| Vol 84, No 4 (2012) |
Editorial |
CHARACTERISTICS OF DIAGNOSTIC APPROACH TO ERYTHROCYTOSIS OF DIFFERENT GENESIS |
|
| Vol 78, No 7 (2003) |
Editorial |
Invasive aspergillesis in immunocompromised patients |
|
| Vol 78, No 8 (2003) |
Editorial |
Therapeutic efficacy of imatinibmesilate (glivek) in chronic phase of myeloid leukemia |
|
